Category Archives: Curation


Public health surveillance has traditionally relied on clinics, hospitals, and laboratories to report cases of disease. But across much of Africa, this system captures only part of the picture. Many people do not seek care, cannot access testing, or are excluded from formal health systems altogether. As a result, outbreaks are often detected late, under-reported, or missed entirely.





A recent report in Nature highlights how wastewater surveillance is changing this reality, using sewage to track disease trends at the community level, even when clinical data is limited.





What is wastewater surveillance?





Wastewater surveillance involves testing sewage for genetic material from pathogens such as viruses and bacteria. When people are infected, traces of these pathogens are shed through bodily waste and end up in wastewater systems. By analysing these samples, scientists can estimate disease circulation across entire communities, without relying on individual testing or hospital visits.





In practical terms, one wastewater sample can represent thousands or even millions of people.





Lessons from South Africa





Researchers in South Africa demonstrated how wastewater monitoring can reveal disease trends that conventional surveillance fails to capture. By comparing viral signals in sewage with reported clinical cases, they found a significant gap between actual infections and officially recorded data.





In several instances, wastewater data showed rising infection levels weeks before clinics recorded an increase in cases. This early signal is especially important in lower-income or underserved areas, where testing rates tend to be lower, and outbreaks are more likely to go unnoticed.





The findings underscore a critical reality: absence of data does not mean absence of disease.





Beyond COVID-19





While wastewater surveillance gained prominence during the COVID-19 pandemic, its applications extend far beyond one virus. Researchers are now detecting genetic material linked to:






  • Measles




  • Mpox




  • Influenza




  • Hepatitis A and E





In some cases, these pathogens were identified in wastewater even when no clinical cases had been officially reported in the area. This positions wastewater surveillance as a powerful early-warning system for emerging and re-emerging diseases.





Why this matters for Africa





Wastewater surveillance offers several advantages that are particularly relevant in African contexts:






  • Equity: It captures health data from entire communities, including people who are not represented in clinical systems.




  • Cost-effectiveness: Monitoring a few sites can be more affordable than mass individual testing.




  • Early detection: Public health authorities can respond sooner, potentially preventing wider outbreaks.




  • Genomic insight: Sequencing wastewater samples allows scientists to track variants and pathogen evolution over time.





For regions facing resource constraints, these benefits can strengthen public health decision-making without placing additional burdens on individuals.





The challenges ahead





Despite its promise, wastewater surveillance is not without limitations. It requires:






  • Laboratory infrastructure and sequencing capacity




  • Skilled personnel for data analysis




  • Sustainable funding and policy support





Encouragingly, continental initiatives, including efforts led by Africa CDC, are working toward integrating wastewater and environmental surveillance into broader disease monitoring systems.





Where MyAfroDNA fits in





At MyAfroDNA, we believe that genomic tools should serve real-world public health needs, especially in underrepresented regions. Wastewater surveillance demonstrates how genomics can move beyond laboratories and clinics to inform population-level health decisions.





As Africa continues to invest in biospecimen science, molecular testing, and genomic research, approaches like wastewater surveillance will be essential for building resilient, inclusive health systems.





Better data leads to better decisions and better outcomes for communities.







Recent advances published in the American Journal of Human Genetics highlight a pivotal shift in how scientists describe human populations in genetic studies — moving away from outdated racial terms toward more precise and meaningful descriptors like ancestry and ethnicity. In deepening our understanding of human genetic variation, language matters — both scientifically and ethically.

For decades, human genetics research sometimes relied on broad, socially loaded terms such as “race” or “Caucasian.” However, analyses tracking terms used in AJHG articles over time show a clear decline in the use of “race” and a rise in the use of labels like “African,” “European,” “Asian,” “ancestry,” and “ethnicity”. This shift reflects a growing recognition that continental labels and ancestry descriptors are more biologically and socially meaningful than simplistic racial categories.

This transition is not just semantic. Accurate terms improve how we design studies, interpret results and communicate findings — especially in genetics and genomic medicine, where variation is often deeply structured by geography, migration and population history rather than socially constructed groupings.

For a company like MyAfroDNA, this conversation underscores why African-centred genomics must be anchored in scientifically precise and culturally respectful language. Africa is the most genetically diverse continent on Earth, and understanding its genetic variation requires nuanced, context-specific frameworks rather than broad, imprecise categories.

By advocating for the use of ancestry and ethnicity labels rooted in deep genomic data — rather than traditional racial descriptors — the field is moving toward more accurate, inclusive and equitable genomics research. This evolution aligns with our mission: to enrich African genomic representation, empower informed interpretation, and advance science that reflects real human diversity.



A landmark study led by researchers from University College London (UCL) and published in Science Advances reveals a previously hidden depth of genetic diversity, migration, and admixture within African populations. Titled “Dense sampling of ethnic groups within African countries reveals fine-scale genetic structure and extensive historical admixture,” the research analysed 1,333 genomes from over 150 ethnic groups across Cameroon, Ghana, Nigeria, Sudan, and the Republic of the Congo.





The findings challenge the often simplistic narratives about African genetic history. The study uncovered fine-scale genetic structure within single countries, showing that even neighbouring ethnic groups may carry distinct ancestral lineages. For instance, western Cameroonian groups exhibit unique ancestry signatures reflecting the region’s long history of local kingdoms and cultural interactions.





Researchers also traced long-distance admixture events, linking populations in northern Cameroon and Sudan with distant groups, suggesting centuries of movement through trade, migration, and empire expansion. In Ghana and Nigeria, they detected intermixing patterns dating back more than 2,000 years, likely connected to shifts in climate and vegetation that encouraged population mobility and contact.





Beyond uncovering these complex patterns, the study highlights an essential truth: Africa’s genomic diversity cannot be fully understood through limited or external data. It underscores the urgency of expanding and diversifying African genomic datasets to ensure equitable representation in global genetics research.





For MyAfroDNA, this research reaffirms our mission to strengthen African-centric molecular testing and biospecimen sourcing for both research and precision medicine. Understanding these fine-scale patterns helps scientists interpret genetic variation more accurately, improving ancestry insights and health-related findings for African communities.





As Africa continues to shape the global genomic landscape, studies like this remind us that every region, community, and ancestry carries its own genetic legacy, one that deserves to be studied, respected, and represented on its own terms.





Read the full research here.



A new study published in The American Journal of Human Genetics reveals how centuries of colonial expansion and the Indian Ocean slave trade shaped South Africa’s genetic landscape, leaving a profound legacy of sex-biased admixture.





Researchers analyzed genetic data from over 1,400 individuals across South Africa to understand how migration and displacement transformed Indigenous communities. The findings show that European male settlers contributed disproportionately to genetic lineages, while Khoe-San women and enslaved women from South and Southeast Asia made major contributions to the maternal gene pool.





Interestingly, while genetic mixing around the Cape was continuous, northern Khoe-San communities experienced a single pulse of European admixture about six to eight generations ago. The Nama people showed unique founder effects, with about 15% of Y-chromosome lineages tracing back to Asia, reflecting the deep genetic impact of forced migrations during colonial times.





This research highlights how genomics can uncover stories of resilience and connection, offering new insight into Africa’s intertwined histories of movement, survival, and identity.





At MyAfroDNA, we are committed to advancing genomics research by providing high-quality African biospecimens and molecular testing services that help decode Africa’s diverse genetic heritage.





Click here for further reading.



In a recent Nature Communications article, Alex M. Vakulskas, Andrew P. Goodman, Paola S. Guerena, William L. Hsieh, Benjamin M. Lane, Joseph N. Blattman, John L. Rinn, and Silvana Konermann present an innovative approach to overcoming one of the biggest challenges in epigenome editing: efficient delivery.





The team developed RENDER (Robust ENveloped Delivery of Epigenome-editor Ribonucleoproteins), a platform that packages CRISPR-based epigenome editors into engineered virus-like particles (eVLPs). Unlike viral vectors or plasmid delivery, which can pose risks of integration and cytotoxicity, RENDER delivers the editors as transient ribonucleoproteins (RNPs), ensuring high specificity and reduced off-target effects.This system was tested across a range of cell types, including iPSC-derived neurons and primary human T cells, showing durable gene silencing from a single treatment.





Remarkably, when applied to neurons carrying the MAPT V337M mutation, RENDER reduced Tau protein expression by more than 60% — a proof-of-concept with implications for treating neurodegenerative diseases.The ability to deliver programmable epigenome editors safely, transiently, and effectively represents a leap forward for gene regulation therapies. With continued optimization, this platform could accelerate progress in epigenetic drug development and broaden research applications. Click here for further reading.





At MyAfroDNA, we understand the importance of access to quality African biospecimens and molecular testing for advancing biomedical innovations like these. Partner with us to power your next research breakthrough.



A new study introduces the South African Blood Regulatory (SABR) resource, a functional genomics dataset derived from >600 individuals from three South Eastern Bantu-speaking populations (Pedi/Bapedi, Tsonga, Zulu). The project integrates whole-genome sequencing and blood transcriptome data to map regulatory variation (expression QTLs / splice QTLs / cell-type interaction QTLs) for 40 blood-cell traits. One major finding: many regulatory variants are unique to individuals of African ancestry, and a substantial fraction are entirely absent in non-African populations.





Compared to the widely used GTEx project (which is heavily biased toward European ancestry), SABR detects more regulatory variants per gene—even though the sample size is smaller. The team also utilizes GWAS summary statistics from African-ancestry participants in the Pan-UK Biobank to demonstrate that SABR enhances the interpretation of genetic associations, specifically identifying putative causal genes and mechanisms linked to blood-related traits and disease risks that would otherwise be more difficult to discern.





SABR’s analysis connects changes in blood cell subtype levels with diseases like HIV, obesity, hypertension, asthma, and the effects of smoking. Several variants that influence disease-relevant cell types or levels are common in SABR but rare or unobserved elsewhere. The full SABR summary statistics are being made publicly available to support researchers.





Read the full article here



A groundbreaking study published in Nature Communications has revealed novel genetic variants associated with carotid intima-media thickness (cIMT), a key marker of early atherosclerosis, among nearly 8,000 adults from sub-Saharan Africa. The research, part of the AWI-Gen project, included participants from Burkina Faso, Ghana, Kenya, and South Africa and marks one of the largest genome-wide association studies (GWAS) on cardiovascular risk in African populations.





Two previously unidentified loci, SIRPA and FBXL17, were found to be significantly associated with cIMT, offering new insight into biological pathways involved in vascular health. Notably, the study also identified sex-specific genetic signals: SNX29 in men, and LARP6 and PROK1 in women, the latter two being enriched for estrogen response genes. These findings suggest different genetic mechanisms for cardiovascular risk between men and women.





Many of the variants identified in this African cohort are either rare or absent in European populations, emphasizing the critical need for diversity in genomic research. This study not only deepens our understanding of cardiovascular disease in African communities but also underscores the importance of building inclusive datasets to drive precision medicine. At MyAfroDNA, we champion this kind of Africa-led genomic science.





Read more on this research here: https://www.nature.com/articles/s41467-022-28276-x



A groundbreaking pair of studies published in Antiquity reveals compelling genetic evidence of West African ancestry in two individuals buried in seventh-century England. The first “West African ancestry in seventh-century England: two individuals from Kent and Dorset” was led by Professor Duncan Sayer of the University of Central Lancashire, examining the female burial from Updown, Kent.






The second, focusing on the male burial at Worth Matravers, Dorset, titled Ancient genomes reveal cosmopolitan ancestry and maternal kinship patterns at post-Roman Worth Matravers, Dorset, was led by Dr. Ceiridwen J. Edwards from the University of Huddersfield.





In both cases, mitochondrial DNA traced maternal lineage to Northern Europe, while autosomal DNA showed clear affinity with present-day Yoruba, Mende, Mandenka, and Esan groups, indicating a West African paternal grandparent.

The Updown burial included a Frankish pot and spoon suggestive of Christian or Byzantine connections, highlighting continental ties, whereas the Dorset individual was interred with local artifacts and a burial companion, underscoring full local integration.





These discoveries represent the first genetic proof of sub-Saharan African connections in Early Medieval Britain, reshaping our understanding of migration, identity, and social complexity in that era.





Read more about this discovery here.







A new study published by our partners, the AfricaBP Open Institute, showcases transformative efforts to harness biodiversity genomics and bioinformatics to drive a sustainable African bioeconomy.





The Africa BioGenome Project (AfricaBP) aims to sequence 105,000 non‑human genomes across Africa, spanning plants, animals, fungi, and protozoa, to support food security, conservation, and biotech innovation. To bridge capacity gaps, the AfricaBP Open Institute organized 31 hands‑on regional workshops in 2024 across five geographic regions, engaging participants from over 50 African countries. These sessions trained 401 African researchers in genome sequencing, gene editing, bioinformatics, molecular biology, ethics, and biobanking, strengthening local research infrastructure and skills.





A highlight case study: the proposed “1000 Moroccan Genome Project,” which illustrates economic returns from local genome sequencing. Analysis shows that a US$20 million investment over 10 years could yield US$40 million in discounted benefits and deliver a benefit–cost ratio (BCR) of 3.29—meaning every dollar invested returns more than three dollars in value—particularly across agriculture, R&D, education, and downstream sectors.





Key recommendations emerge: integrate biodiversity genomics and bioinformatics into national bioeconomy strategies, expand capacity‑building initiatives, build regional sequencing hubs, and foster ethical, inclusive data-sharing policies. Strategic investment in these domains positions African nations to capitalize on their unique biodiversity and reclaim ownership of genomic science—a powerful lever toward sustainable development and regional innovation rooted in African knowledge and priorities  .





In short, AfricaBP’s model provides a scalable path for leveraging genomic science to fuel a resilient, inclusive African bioeconomy driven by regional talent and locally generated data. Read more here.







A landmark discovery, scientists have sequenced the genome of a man buried around 4,500–4,800 years ago at Nuwayrat in Middle Egypt, marking the oldest complete genome ever recovered from the region. Likely a potter in his 60s, the man was buried in a sealed ceramic jar carved into rock, a burial that helped preserve his DNA despite Egypt’s harsh climate.





This genome confirms ancient people-to-people contact between Egypt and Mesopotamia, echoing archaeological evidence of shared pottery styles and writing systems. The Nile likely served not just as a trade route for goods and ideas, but for human migration too.





The discovery demonstrates that DNA preservation is possible and important to build a clearer understanding of Africa's genetic history.





Learn more about this research here: https://www.nature.com/articles/d41586-025-02102-y